Ablation technologies are driven by cancer therapy, general surgery and cardiovascular disease treatments

Technologies used for medical and surgical ablation are used in virtually all clinical practices.  Ablation is the therapeutic destruction or excision of tissue for purposes ranging from the destruction and excision of cancerous or otherwise diseased tissue, the cauterizing of wounds, the formation of therapeutic lesions as in ablation of abnormally conducting cardiac tissue in atrial fibrillation and others.

Ablation technology types are differentiated, for the most part, on the kind of energy employed.  These include light/laser, radiation, radiofrequency, microwave, ultrasound, cryo, electrical, thermal and hydromechanical.

While the number and type of ablation technologies makes them versatile tools for use in a wide range of general surgical procedures, the predominant use of ablation technologies is in cancer therapy for the excision and destruction of cancerous tissue, followed by general surgery applications, then cardiovascular disease applications. Below is the share of the global medical technology product revenues in ablation by major clinical area of application.

Share of Global Medical Product Revenues in Ablation, by Clinical Area

Source:  "Ablation Technologies Worldwide Market, 2009-2019: Products, Technologies, Markets, Companies and Opportunities", MedMarket Diligence, LLC, Report #A145.

The current aggregate market for ablation technologies worldwide stands at over $11 billion, with most technology types growing at double-digit rates as these technologies are made more and more routine in clinical practice and as physicians increase the patient caseload (and indications) targeted by these technologies.

Leave a Reply